BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  It’s All MDS and AML Trials Go for Gilead as FDA Lifts Partial Hold

  The FDA’s decision to lift the hold directive on April 11 involving the investigational drug magrolimab follows a comprehensive review of each trial’s safety data.

  April 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Moderna Celebrates Appointment of New CFO, Recalls Vaccine Lots in Europe

  Moderna tapped Jorge Gomez to take over the role of chief financial officer next month upon the retirement of David Meline, the current company CFO.

  April 12, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Myovant Stumbles on FDA Concerns Over Pfizer-Partnered Endometriosis Drug

  Myovant said that the FDA provided notice it had found deficiencies that will preclude any potential discussion of labeling or post-marketing requirements at this time.

  April 12, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  It’s Who You Know: A Guide to Networking in the Life Science Industry

  Even if you aren’t looking for a new role in biopharma, nurturing relationships will only benefit you in the long run. To help, here is a complete guide to networking in the life science industry.

  April 12, 2022

   · 

  4 min read

   · 

  Christie Adams
• 

  Drug Development

  Aeglea Presents Robust Data in Rare Metabolic Disorder, Submits First BLA

  As Aeglea presents the data this week at the Society for Inherited Metabolic Disorders (SIMD), its stock has responded to both announcements with a strong leap.

  April 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  Novartis Highlights Early Data from Potential Lumakras Competitor at AACR

  Although the data was preliminary from a Phase Ib trial, investors are already speculating that the drug - when and if it makes it to regulators - could compete with Amgen’s Lumakras (sotorasib).

  April 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Aurion Biotech Pots $120M to Advance Cell Therapy for Eye Diseases

  The funding will be used to push forward Aurion’s cell therapy program for corneal edema secondary to endothelial dysfunction.

  April 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Cimeio Therapeutics Wins $50M to Power Cell-Shielding Technology

  Cimeio Therapeutics, a novel cell therapy startup, announced the completion of a $50 million Series A financing round Wednesday morning.

  April 12, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  AstraZeneca Rolls into AACR with 60 Presentations, New SVP of Early Oncology

  “I want to put together cures for AstraZeneca and patients,” Matthew Ellis, the company’s new SVP of early oncology told BioSpace in an interview.

  April 12, 2022

   · 

  5 min read

   · 

  Alex Keown
• 

  Drug Development

  Lilly Poised to Take on Competitors in Atopic Dermatitis

  Eli Lilly has shared positive results of lebrikizumab combination therapy with topical corticosteroids, which is intended to treat atopic dermatitis (AD).

  April 12, 2022

   · 

  2 min read

   · 

  Hayley Shasteen